Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Providing the New Generation of Nano-Based Molecular Technology for the Early Detection of Bacteria, Viruses and Cancer at the Point of Care

Obiettivo

There is a need for cost-effective molecular point of care diagnostic tools to provide better healthcare to patients and better agility to our healthcare system. And what about going one step further by extending the limits of molecular diagnostics to the nano-scale?
We have developed the nano-technology-based solution nano4. nano4 is a fast and user-friendly nano-based diagnostic technology suitable for use at the POC. nano4 represents a highly specific and sensitive nanotechnology for in vitro molecular diagnostics. nano4 uses gold nano-probes to recognize the complementary DNA/RNA strand and yield a color output that allows for quick decision making.
Our ultimate objective is to leverage the diagnostic possibilities of nano-technology for all its applications in medicine and life science, thereby expanding the current possibilities of molecular analysis. We are convinced that the fast, accurate, low-cost and user-friendly diagnostic of certain viruses, pathogens and cancer-types through nano4 will help healthcare decision-makers to act quickly, thereby saving lives, pain, mistakes and even preventing epidemics. Our business objective is to make nano4 a standard POC diagnostics technology present at each POC globally and to become the global leader in nano-based molecular diagnostic technology.
Easily accessible fast molecular testing is a tremendous challenge especially when reliable results are needed quickly and cost-efficiently. Especially now, with the migrant crisis, cases of TB and Zika are more frequent. Each application of nano4 can answer a specific European challenge.
We will conduct several activities including production process analysis, cost-benefit analysis, partner search, market research, customer validation activities, price acceptance analysis, focus groups, surveys and strategic planning, risk and regulatory environment assessment, as well as document drafting.

Invito a presentare proposte

H2020-SMEInst-2016-2017

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEINST-1-2016-2017

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

NANO4 GLOBAL LDA
Contribution nette de l'UE
€ 50 000,00
Indirizzo
Estrada da Granja do Marquês, nº 339, Armazém B
2710-142 Sintra
Portogallo

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00